OSSIO key facts
- Operator of an orthopedic fixation company intended to provide the first credible replacement for metal implants.
- OSSIO’s last known valuation is $141.7M.
- It has raised $102.1M; the latest was Later Stage VC ($27.6M) in Dec 2024.
- Notable investors include OurCrowd, Arc Ventures (United States), Courage Capital Management, MVM Partners, OCV Partners — 8 tracked in total.
- Status: Privately Held (backing).
- ·Watch OSSIO: the Monday email on marks, rounds and moves
OSSIO funding rounds
No funding rounds for OSSIO are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
OSSIO valuation
OSSIO's last known valuation is $142 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
OSSIO investors
8 investors are on record for OSSIO, including OurCrowd, Arc Ventures (United States), Courage Capital Management and MVM Partners.
About OSSIO
Operator of an orthopedic fixation company intended to provide the first credible replacement for metal implants. The company's fixation devices utilize intelligent bone regeneration technology and are based on a biocomposite material platform and also offer reinforcing mineral fibers made of a mineral blend, enabling patients to regenerate tissues and bones and recover from orthopedic disorders.
- Sector
- Healthcare
- HQ
- Woburn, MA, United States
- Founded
- 2014
- Employees
- 137
- Website
- ossio.io/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
OSSIO’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.